Acute generalized exanthematous pustulosis caused by daptomycin in a critically ill burn victim

Intern Med. 2014;53(5):511-4. doi: 10.2169/internalmedicine.53.0679.

Abstract

Acute generalized exanthematous pustulosis (AGEP) is a self-limiting type of drug eruption that frequently occurs as a reaction to antibiotics, particularly penicillins or macrolides. Daptomycin (DAP) is a newly developed antibiotic that specifically targets methicillin-resistant Staphylococcus aureus infection. We herein present the case of a 77-year-old severe burn victim who was diagnosed with DAP-induced AGEP while receiving treatment in an intensive care unit. Although rare, physicians should be aware that the administration of DAP can cause AGEP, which may complicate the clinical course of patients with a high fever and inflammation.

Publication types

  • Case Reports

MeSH terms

  • Acute Generalized Exanthematous Pustulosis / diagnosis
  • Acute Generalized Exanthematous Pustulosis / etiology*
  • Aged
  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use
  • Burns / complications*
  • Burns / diagnosis
  • Critical Illness*
  • Daptomycin / adverse effects*
  • Daptomycin / therapeutic use
  • Diagnosis, Differential
  • Humans
  • Male
  • Methicillin-Resistant Staphylococcus aureus
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / microbiology
  • Trauma Severity Indices
  • Wound Infection / drug therapy*
  • Wound Infection / microbiology

Substances

  • Anti-Bacterial Agents
  • Daptomycin